Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR1 | P32246 | 2/20 | 0.45 |
| ▸ | CCR8 | P51685 | 2/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.45 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.44 |
| ▸ | PDE4A | P27815 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.40 |
| ▸ | TOP1 | P11387 | 3/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 4/20 | 0.39 |
| ▸ | ABCG2 | Q9UNQ0 | 4/20 | 0.38 |
| ▸ | BRD4 | O60885 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20726910 | 0.97 | CCR1 (0.47) | CCR1CCR8L3MBTL1PIK3CDPDE4A | |
| SCHEMBL17720982 | 0.96 | CCR1 (0.44) | CCR1CCR8L3MBTL1PIK3CDPDE4A | |
| SCHEMBL19009572 | 0.96 | CCR1 (0.44) | CCR1CCR8L3MBTL1PIK3CDPDE4A | |
| SCHEMBL22963643 | 0.94 | ALDH1A1 (0.48) | CCR1CCR8L3MBTL1PIK3CDPDE4A | |
| SCHEMBL22963270 | 0.94 | ALDH1A1 (0.48) | CCR1CCR8L3MBTL1PIK3CDPDE4A | |
| SCHEMBL22963326 | 0.93 | ALDH1A1 (0.47) | CCR1CCR8L3MBTL1PIK3CDPDE4A | |
| SCHEMBL22963717 | 0.93 | ALDH1A1 (0.47) | CCR1CCR8L3MBTL1PIK3CDPDE4A | |
| SCHEMBL22963627 | 0.93 | ALDH1A1 (0.47) | CCR1CCR8L3MBTL1PIK3CDPDE4A | |
| SCHEMBL22963721 | 0.93 | ALDH1A1 (0.47) | CCR1CCR8L3MBTL1PIK3CDPDE4A | |
| SCHEMBL22963581 | 0.93 | ALDH1A1 (0.47) | CCR1CCR8L3MBTL1PIK3CDPDE4A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3441391-B1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO LTD (KR) | 2020-09-02 | — | — | EP | disclosed |
| US-20190051841-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2019-02-14 | — | — | US | disclosed |
| EP-3441391-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | Samsung Display Co., Ltd. (KR) | 2019-02-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190051841-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | AOC2, CYP1A1, CRY1 | CCR1 2508/4885CCR8 3502/4885L3MBTL1 370/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.